Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
September-2021 Volume 22 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2021 Volume 22 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

The effects of compound centella formula on OxInflammation and silent information regulator 1 in a high‑fat diet/streptozotocin‑induced diabetic kidney disease rat model

  • Authors:
    • Qin Zhu
    • Xiao-Hong Li
    • Hong-Yu Chen
    • Qin-Yang Jin
  • View Affiliations / Copyright

    Affiliations: Department of Nephrology, Key Laboratory of Zhejiang Province, Management of Kidney Disease, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang 310007, P.R. China, Department of Cardiology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China
    Copyright: © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 962
    |
    Published online on: July 7, 2021
       https://doi.org/10.3892/etm.2021.10394
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The Chinese decoction compound centella formula (CCF) is clinically effective against diabetic kidney disease (DKD), but the exact mechanism remains unclear. The present study aimed to investigate the effects of CCF on OxInflammation and silent information regulator 1 (SIRT1) levels in rats with streptozotocin (STZ)‑induced diabetes. Sprague‑Dawley rats were divided into CCF, losartan, diabetic control (DC) and normal control (NC) groups (n=7). Except for the NC, all subgroups of rats were fed a high‑fat diet for 112 days and received a single intraperitoneal injection of 35 mg/kg STZ on day 29. All rats were sacrificed on day 112. High‑performance liquid chromatography was performed to analyse asiaticoside, astragaloside and triptolide levels in CCF (0.3400, 0.0640 and 0.0001 mg/ml, respectively). Fasting blood glucose, urine protein‑to‑creatinine ratio, serum creatinine and blood urea nitrogen were quantified. Periodic acid Schiff staining, H&E staining and transmission electron microscopy were used to examine kidney pathological changes. The mRNA and protein expression levels of SIRT1 in renal tissues were analysed by reverse transcription‑quantitative PCR, western blotting and immunohistochemistry. Oxidative stress was evaluated by measuring the levels of superoxide dismutase (SOD), malondialdehyde (MDA) and nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4) in renal tissues. TNF‑α and NF‑κB p65 subunit in renal tissues were assessed for inflammation. Compared with the rats in the NC group, the rats in the DC group exhibited renal injury with proteinuria, decreased expression levels of SIRT1 and SOD (P<0.01) and increased levels of MDA, NOX4, TNF‑α and NF‑κB p65 (P<0.01). CCF treatment reduced proteinuria (P<0.01), alleviated renal damage, decreased MDA, NOX4, TNF‑α and NF‑κB p65 levels (P<0.01), increased SOD levels (P<0.05) and increased SIRT1 mRNA and protein expression levels (P<0.01). The present study indicates that CCF effectively protects the kidney from diabetes by inhibiting OxInflammation and upregulating SIRT1.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

König A, Schwarzinger B, Stadlbauer V, Lanzerstorfer P, Iken M, Schwarzinger C, Kolb P, Schwarzinger S, Mörwald K, Brunner S, et al: Guava (Psidium guajava) fruit extract prepared by supercritical CO2 extraction inhibits intestinal glucose resorption in a double-blind, randomized clinical study. Nutrients. 11(1512)2019.PubMed/NCBI View Article : Google Scholar

2 

Bakris GL, Hahr A, Khardori R, Koya D, Molitch M, Prischl FC, Schernthaner G and Thajudeen B: Managing diabetic nephropathies in clinical practice. Overview of diabetic nephropathy. 10.1007/978-3-319-08873-0: 1-21, 2017.

3 

Varga ZV, Giricz Z, Liaudet L, Haskó G, Ferdinandy P and Pacher P: Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy. Biochim Biophys Acta. 1852:232–242. 2014.PubMed/NCBI View Article : Google Scholar

4 

Flyvbjerg A: The role of the complement system in diabetic nephropathy. Nat Rev Nephrol. 13:311–318. 2017.PubMed/NCBI View Article : Google Scholar

5 

Choi JS, Kim J, Park J, Pyo S, Hong YK, Ku S and Kim MR: Blood glycemia-modulating effects of melanian snail protein hydrolysates in mice with type II diabetes. Int J Mol Med. 39:1437–1451. 2017.PubMed/NCBI View Article : Google Scholar

6 

Mizuno Y, Yamamotoya T, Nakatsu Y, Ueda K, Matsunaga Y, Inoue MK, Sakoda H, Fujishiro M, Ono H, Kikuchi T, et al: Xanthine oxidase inhibitor febuxostat exerts an anti-inflammatory action and protects against diabetic nephropathy development in KK-Ay obese diabetic mice. Int J Mol Sci. 20(4680)2019.PubMed/NCBI View Article : Google Scholar

7 

Rajesh M, Mukhopadhyay P, Bátkai S, Patel V, Saito K, Matsumoto S, Kashiwaya Y, Horváth B, Mukhopadhyay B, Becker L, et al: Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol. 56:2115–2125. 2010.PubMed/NCBI View Article : Google Scholar

8 

Duecker R, Baer P, Eickmeier O, Strecker M, Kurz J, Schaible A, Henrich D, Zielen S and Schubert R: Oxidative stress-driven pulmonary inflammation and fibrosis in a mouse model of human ataxia-telangiectasia. Redox Biol. 14:645–655. 2018.PubMed/NCBI View Article : Google Scholar

9 

Valacchi G, Virgili F, Cervellati C and Pecorelli A: OxInflammation: From subclinical condition to pathological biomarker. Front Physiol. 9(858)2018.PubMed/NCBI View Article : Google Scholar

10 

Bonkowski M and Sinclair D: Slowing ageing by design: The rise of NAD+ and sirtuin-activating compounds. Nat Rev Mol Cell Biol. 17:679–690. 2016.PubMed/NCBI View Article : Google Scholar

11 

Guo R, Liu W, Liu B, Zhang B, Li W and Xu Y: SIRT1 suppresses cardiomyocyte apoptosis in diabetic cardiomyopathy: An insight into endoplasmic reticulum stress response mechanism. Int J Cardiol. 191:36–45. 2015.PubMed/NCBI View Article : Google Scholar

12 

Hao CM and Haase V: Sirtuins and their relevance to the kidney. J Am Soc Nephrol. 21:1620–1627. 2010.PubMed/NCBI View Article : Google Scholar

13 

Wakino S, Hasegawa K and Itoh H: Sirtuin and metabolic kidney disease. Kidney Int. 88:691–698. 2015.PubMed/NCBI View Article : Google Scholar

14 

Zhu Q, Zeng J, Li J, Chen X, Miao J, Jin Q and Chen H: Effects of compound centella on oxidative stress and Keap1-Nrf2-ARE pathway expression in diabetic kidney disease rats. Evid Based Complement Alternat Med. 2020(9817932)2020.PubMed/NCBI View Article : Google Scholar

15 

Mengjie Z, Ziyang B, Liqiang Y, Danfeng G, Lin W and Jiao Z: Clinical Study on Modified Compound Jixuecao Tang for Chronic Glomerulonephritis and Chronic Kidney Disease at the Third Stage. Journal of New Chinese Medicine: 2019.

16 

Spiers DE and Candas V: Relationship of skin surface area to body mass in the immature rat: A reexamination. J Appl Physiol Respir Environ Exerc Physiol. 56:240–243. 1984.PubMed/NCBI View Article : Google Scholar

17 

Ding Y, Zhang R, Zhang K, Lv X, Chen Y, Li A, Wang L, Zhang X and Xia Q: Nischarin is differentially expressed in rat brain and regulates neuronal migration. PloS One. 8(e54563)2013.PubMed/NCBI View Article : Google Scholar

18 

Zhu X, Chen Y, Chen Q, Yang H and Xie X: Astaxanthin promotes Nrf2/ARE signaling to alleviate renal fibronectin and collagen IV accumulation in diabetic rats. J Diabetes Res. 2018(6730315)2018.PubMed/NCBI View Article : Google Scholar

19 

Artacho-Perula E, Roldan-Villalobos R, Salcedo-Leal I and Vaamonde-Lemos R: Stereological estimates of volume-weighted mean glomerular volume in streptozotocin-diabetic rats. Lab Invest. 68:56–61. 1993.PubMed/NCBI

20 

Liu HF, Guo LQ, Huang YY, Chen K, Tao JL, Li SM and Chen XW: Thiazolidinedione attenuate proteinuria and glomerulosclerosis in Adriamycin-induced nephropathy rats via slit diaphragm protection. Nephrology (Carlton). 15:75–83. 2010.PubMed/NCBI View Article : Google Scholar

21 

Loeffler I and Wolf G: Pathophysiologie der diabetischen Nephropathie. Der Nephrologe. 12:391–399. 2017.

22 

Karolina L, Hannes O, Risul A, Arvind P, Regina G, Taylor RF, Moosa M, Ann C, Karolina K and Larsson TE: Arterial klotho expression and FGF23 effects on vascular calcification and function. Plos One. 8(e60658)2013.PubMed/NCBI View Article : Google Scholar

23 

Martynyuk L, Martynyuk L, Ruzhytska O and Martynyuk O: Effect of the herbal combination canephron N on diabetic nephropathy in patients with diabetes mellitus: Results of a comparative cohort study. J Altern Complement Med. 20:472–478. 2014.PubMed/NCBI View Article : Google Scholar

24 

Tavafi M: Diabetic nephropathy and antioxidants. J Nephropathology. 2:20–27. 2013.PubMed/NCBI View Article : Google Scholar

25 

Gosmanov AR, Wall BM and Gosmanova EO: Diagnosis and treatment of diabetic kidney disease. Am J Med Sci. 347:406–413. 2014.PubMed/NCBI View Article : Google Scholar

26 

Sego S: Pathophysiology of diabetic nephropathy. Nephrol Nurs J. 34:631–633. 2008.PubMed/NCBI

27 

Magalhães DA, Kume WT, Correia FS, Queiroz TS, Allebrandt Neto EW, Santos MP, Kawashita NH and França SA: High-fat diet and streptozotocin in the induction of type 2 diabetes mellitus: A new proposal. An Acad Bras Ciênc. 91(e20180314)2019.PubMed/NCBI View Article : Google Scholar

28 

Guex CG, Reginato FZ, de Jesus PR, Brondani JC, Lopes GH and Bauermann LF: Antidiabetic effects of Olea europaea L. leaves in diabetic rats induced by high-fat diet and low-dose streptozotocin. J Ethnopharmacol. 235:1–7. 2019.PubMed/NCBI View Article : Google Scholar

29 

Ahad A, Ganai AA, Mujeeb M and Siddiqui WA: Ellagic acid, an NF-κB inhibitor, ameliorates renal function in experimental diabetic nephropathy. Chemico-Biological Interactions. 219:64–75. 2014.PubMed/NCBI View Article : Google Scholar

30 

Ahad A, Ganai AA, Mujeeb M and Siddiqui WA: Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats. Toxicol Appl Pharmacol. 279:1–7. 2014.PubMed/NCBI View Article : Google Scholar

31 

Serdar M, Sertoglu E, Uyanik M, Tapan S, Bilgi C and Kurt I: Comparison of 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels using mass spectrometer and urine albumin creatinine ratio as a predictor of development of diabetic nephropathy. Free Radic Res. 46:1291–1295. 2012.PubMed/NCBI View Article : Google Scholar

32 

Yang M, Jun L, Zhou X, Ding H, Xu J, Yang B, Sun B, Xiao D, Yu J and Gong Q: Correlation analysis between serum vitamin D levels and lower extremity macrovascular complications in individuals with type 2 diabetes mellitus. J Diabetes Res. 2019(4251829)2019.PubMed/NCBI View Article : Google Scholar

33 

Lampropoulou IT, Stangou M, Papagianni A, Didangelos T, Iliadis F and Efstratiadis G: TNF-α and microalbuminuria in patients with type 2 diabetes mellitus. J Diabetes Res. 2014(394206)2014.PubMed/NCBI View Article : Google Scholar

34 

Malikova J, Zdarilova A and Hlobilkova A: Effects of sanguinarine and chelerythrine on the cell cycle and apoptosis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 150:5–12. 2006.PubMed/NCBI View Article : Google Scholar

35 

Liu T, Zhang L, Joo D and Sun SC: NF-κB signaling in inflammation. Signal Transduct Target Ther. 2(17023)2017.PubMed/NCBI View Article : Google Scholar

36 

Xu XY and Ye SW: Efficacy assessment of treating post-stroke shoulder-hand syndrome patients of yin deficiency yang hyperactivity with blood stasis stagnation collaterals syndrome by yishen tongluo decoction. Zhongguo Zhong Xi Yi Jie He Za Zhi. 34:1069–1073. 2014.PubMed/NCBI(Article in Chinese).

37 

Kalantarinia K, Awad AS and Siragy HM: Urinary and renal interstitial concentrations of TNF-α increase prior to the rise in albuminuria in diabetic rats. Kidney Int. 64:1208–1213. 2003.PubMed/NCBI View Article : Google Scholar

38 

Takebayashi K, Matsumoto S, Aso Y and Inukai T: Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy. J Clin Endocrinol Metab. 91:2214–2217. 2006.PubMed/NCBI View Article : Google Scholar

39 

Kowalczuk K and Stryjecka-Zimmer M: The influence of oxidative stress on the level of malondialdehyde (MDA) in different areas of the rabbit brain. Ann Univ Mariae Curie Sklodowska Med. 57:160–164. 2002.PubMed/NCBI

40 

Kaefer M, De Carvalho JA, Piva SJ, da Silva DB, Becker AM, Sangoi MB, Almeida TC, Hermes CL, Coelho AC, Tonello R, et al: Plasma malondialdehyde levels and risk factors for the development of chronic complications in type 2 diabetic patients on insulin therapy. Clin Lab. 58:973–978. 2012.PubMed/NCBI

41 

Li X, Cai W, Lee K, Liu B, Deng Y, Chen Y, Zhang X, He J and Zhong Y: Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes. Sci Rep. 7(14603)2017.PubMed/NCBI View Article : Google Scholar

42 

Ribaldo PD, Souza DS, Biswas SK, Block K, Faria J, Lopes de Faria JM and Lopes de Faria JB: Green tea (Camellia sinensis) attenuates nephropathy by downregulating Nox4 NADPH oxidase in diabetic spontaneously hypertensive rats. J Nutr. 139:96–100. 2009.PubMed/NCBI View Article : Google Scholar

43 

Peng Q, Liu F and Liang X: Superoxide dismutase and plant resistance to the environmental stress. Heilongjiang Agricultural Science. 1:31–34. 2002.

44 

Samarghandian S, Borji A, Delkhosh M and Samini F: Safranal treatment improves hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats. J Pharm Pharm Sci. 16:352–362. 2013.PubMed/NCBI View Article : Google Scholar

45 

Tisato V, Gallo S, Melloni E, Celeghini C, Passaro A, Zauli G, Secchiero P, Bergamini C, Trentini A, Bonaccorsi G, et al: TRAIL and ceruloplasmin inverse correlation as a representative crosstalk between inflammation and oxidative stress. Mediators Inflamm. 2018(9629537)2018.PubMed/NCBI View Article : Google Scholar

46 

Elmarakby AA and Sullivan JC: Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther. 30:49–59. 2012.PubMed/NCBI View Article : Google Scholar

47 

Webster BR, Lu Z, Sack MN and Scott I: The role of sirtuins in modulating redox stressors. Free Radical Biol Med. 52:281–290. 2011.PubMed/NCBI View Article : Google Scholar

48 

Yang X, Zhang B, Lu X, Yan M, Wen Y, Zhao T and Li P: Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: Post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease. BMC Complement Altern Med. 16(246)2016.PubMed/NCBI View Article : Google Scholar

49 

Iskender H, Dokumacioglu E, Sen TM, Ince I, Kanbay Y and Saral S: The effect of hesperidin and quercetin on oxidative stress, NF-κB and SIRT1 levels in a STZ-induced experimental diabetes model. Biomed Pharmacother. 90:500–508. 2017.PubMed/NCBI View Article : Google Scholar

50 

Huang K, Gao X and Wei W: The crosstalk between Sirt1 and Keap1/Nrf2/ARE anti-oxidative pathway forms a positive feedback loop to inhibit FN and TGF-β1 expressions in rat glomerular mesangial cells. Exp Cell Res. 361:63–72. 2017.PubMed/NCBI View Article : Google Scholar

51 

Du YG, Zhang KN, Gao ZL, Dai F, Wu XX and Chai KF: Tangshen formula improves inflammation in renal tissue of diabetic nephropathy through SIRT1/NF-κB pathway. Exp Ther Med. 15:2156–2164. 2018.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhu Q, Li X, Chen H and Jin Q: The effects of compound centella formula on OxInflammation and silent information regulator 1 in a high‑fat diet/streptozotocin‑induced diabetic kidney disease rat model. Exp Ther Med 22: 962, 2021.
APA
Zhu, Q., Li, X., Chen, H., & Jin, Q. (2021). The effects of compound centella formula on OxInflammation and silent information regulator 1 in a high‑fat diet/streptozotocin‑induced diabetic kidney disease rat model. Experimental and Therapeutic Medicine, 22, 962. https://doi.org/10.3892/etm.2021.10394
MLA
Zhu, Q., Li, X., Chen, H., Jin, Q."The effects of compound centella formula on OxInflammation and silent information regulator 1 in a high‑fat diet/streptozotocin‑induced diabetic kidney disease rat model". Experimental and Therapeutic Medicine 22.3 (2021): 962.
Chicago
Zhu, Q., Li, X., Chen, H., Jin, Q."The effects of compound centella formula on OxInflammation and silent information regulator 1 in a high‑fat diet/streptozotocin‑induced diabetic kidney disease rat model". Experimental and Therapeutic Medicine 22, no. 3 (2021): 962. https://doi.org/10.3892/etm.2021.10394
Copy and paste a formatted citation
x
Spandidos Publications style
Zhu Q, Li X, Chen H and Jin Q: The effects of compound centella formula on OxInflammation and silent information regulator 1 in a high‑fat diet/streptozotocin‑induced diabetic kidney disease rat model. Exp Ther Med 22: 962, 2021.
APA
Zhu, Q., Li, X., Chen, H., & Jin, Q. (2021). The effects of compound centella formula on OxInflammation and silent information regulator 1 in a high‑fat diet/streptozotocin‑induced diabetic kidney disease rat model. Experimental and Therapeutic Medicine, 22, 962. https://doi.org/10.3892/etm.2021.10394
MLA
Zhu, Q., Li, X., Chen, H., Jin, Q."The effects of compound centella formula on OxInflammation and silent information regulator 1 in a high‑fat diet/streptozotocin‑induced diabetic kidney disease rat model". Experimental and Therapeutic Medicine 22.3 (2021): 962.
Chicago
Zhu, Q., Li, X., Chen, H., Jin, Q."The effects of compound centella formula on OxInflammation and silent information regulator 1 in a high‑fat diet/streptozotocin‑induced diabetic kidney disease rat model". Experimental and Therapeutic Medicine 22, no. 3 (2021): 962. https://doi.org/10.3892/etm.2021.10394
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team